tailieunhanh - Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model

Both modified FOLFIRINOX (mFFX) and gemcitabine/nab-paclitaxel chemotherapy regimens have been shown to improve clinical outcomes in patients with pancreatic cancer, and are often used interchangeably as the standard of care. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN